Publications

2024

339.
Bojmar L., Zambirinis C. P., Hernandez J. M. et al. (2024) Nature Medicine. 30, 8, p. 2170-2180  Abstract [All authors]
338.
Lim L. Q. J., Adler L., Hajaj E. et al. (2024) Nature metabolism. 6, 7, p. 1294-1309  Abstract [All authors]
337.
Lü Y. Q., Cho T., Mukherjee S. et al. (2024) Molecular Systems Biology. 20, 6, p. 719-740  Abstract [All authors]
336.
Böpple K., Oren Y., Henry W. S. et al. (2024) Cell Death and Disease. 15, 290.  Abstract [All authors]
335.
Abbas R., Hartmann O., Asiss D. T. et al. (2024) Apoptosis. 29, 7-8, p. 1145-1160  Abstract [All authors]
334.
Oren M. & Prives C. (2024) Cell. 187, 7, p. 1569-1573  Abstract

2023

333.
Gershoni A., Hassin O., Nataraj N. B. et al. (2023) Molecular Oncology. 17, 12, p. 2675-2693  Abstract [All authors]
332.
Hassin O., Sernik M., Seligman A. et al. (2023) Proceedings of the National Academy of Sciences of the United States of America. 120, 52, e231146012.  Abstract [All authors]
331.
Michael D., Feldmesser E., Gonen C. et al. (2023) FEBS Letters. 597, 9, p. 1233-1245  Abstract [All authors]
330.
Vitale I., Pietrocola F., Guilbaud E. et al. (2023) Cell Death and Differentiation. 30, 5, p. 1097-1154  Abstract [All authors]
329.
Venghateri J. B., Dassa B., Morgenstern D., Shreberk-Shaked M., Oren M. & Geiger B. (2023) Cell Death and Disease. 14, 4, 290.  Abstract
328.
Hassin O. & Oren M. (2023) Nature reviews. Drug discovery. 22, 2, p. 127-144  Abstract
327.
Aylon Y., Furth N., Mallel G. et al. (2023) Nature Communications. 14, 1, 133.  Abstract [All authors]

2022

326.
Aylon Y., Furth N., Mallel G. et al. (2022) Nature Communications. 13, 1, 7199.  Abstract [All authors]
325.
Noronha A., Belugali Nataraj N., Sang Lee J. et al. (2022) Cancer Discovery. 12, 11, p. 2666-2683  Abstract [All authors]
324.
Tuval A., Brilon Y., Azogy H. et al. (2022) Haematologica. 107, 11, p. 2548-2561  Abstract [All authors]
323.
Hassin O., Nataraj N. B., Shreberk-Shaked M. et al. (2022) Nature Communications. 13, 1, 2800.  Abstract [All authors]
322.
Mukherjee S., Maddalena M., Lü Y. et al. (2022) Proceedings of the National Academy of Sciences. 119, 17, e211964411.  Abstract [All authors]

2021

321.
Maddalena M., Mallel G., Nataraj N. B. et al. (2021) Proceedings of the National Academy of Sciences. 118, 23, e202563111.  Abstract [All authors]
320.
Ghosh S., Nataraj N. B., Noronha A. et al. (2021) Cell Reports. 35, 8, 109181.  Abstract [All authors]

2020

319.
Shreberk-Shaked M., Dassa B., Sinha S. et al. (2020) Cancer Research. 80, 19, p. 4145-4157  Abstract [All authors]
318.
Benor G., Fuks G., Chin S. et al. (2020) Molecular Oncology. 14, 8, p. 1640-1652  Abstract [All authors]
317.
Hoshino A., Kim H. S., Bojmar L. et al. (2020) Cell. 182, 4, p. 1044-1061.e18  Abstract [All authors]
316.
Kadosh E., Snir-Alkalay I., Venkatachalam A. et al. (2020) Nature. 7827, p. 133-+  Abstract [All authors]

2019

315.
Oren M. (2019) Journal of Molecular Cell Biology. 11, 7, p. 539-543  Abstract
314.
Shreberk-Shaked M. & Oren M. (2019) Molecular Oncology. 13, 6, p. 1335-1341  Abstract
313.
Hooda J., Novak M., Salomon M. P. et al. (2019) Cancer Research. 79, 4, p. 760-772  Abstract [All authors]

2018

312.
Furth N., Pateras I. S., Rotkopf R. et al. (2018) Life science alliance. 1, 5, 201800171.  Abstract [All authors]
311.
Minzel W., Venkatachalam A., Fink A. et al. (2018) Cell. 175, 1, p. 171-185  Abstract [All authors]
310.
Kotler E., Segal E. & Oren M. (2018) Molecular & cellular oncology. 5, 6, 1511207.  Abstract
309.
Kotler E., Shani O., Goldfeld G. et al. (2018) Molecular Cell. 71, 1, p. 178-190.e8  Abstract [All authors]
308.
Jethwa A., Slabicki M., Huellein J. et al. (2018) Blood. 131, 25, p. 2789-2802  Abstract [All authors]
307.
Arandkar S., Furth N., Elisha Y. et al. (2018) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415  Abstract [All authors]
306.
Ghannam-Shahbari D., Jacob E., Kakun R. R. et al. (2018) Oncogene. 37, 17, p. 2213-2224  Abstract [All authors]
305.
Solomon H., Dinowitz N., Pateras I. S. et al. (2018) Oncogene. 37, 12, p. 1669-1684  Abstract [All authors]
304.
Galluzzi L., Vitale I., Aaronson S. A. et al. (2018) Cell Death and Differentiation. 25, 3, p. 486-541  Abstract [All authors]
303.
Furth N., Aylon Y. & Oren M. (2018) Cell Death and Differentiation. 25, p. 81-92  Abstract

2017

302.
Enuka Y., Feldman M. E., Chowdhury A. et al. (2017) Nucleic Acids Research. 45, 22, p. 1268112699  Abstract [All authors]
301.
Spolverini A., Fuchs G., Bublik D. R. & Oren M. (2017) Oncogene. 36, 42, p. 5819-5828  Abstract
300.
Aylon Y. & Oren M. (2017) Cancer Cell. 32, 4, p. 397-399  Abstract
299.
Tovy A., Spiro A., McCarthy R. et al. (2017) GENES & DEVELOPMENT. 31, 10, p. 959-972  Abstract
[All authors]
298.
Tarcic O., Granit R. Z., Pateras I. S. et al. (2017) Cell Death and Differentiation. 24, 4, p. 694-704  Abstract [All authors]
297.
Bublik D. R., Bursac S., Sheffer M. et al. (2017) Proceedings of the National Academy of Sciences of the United States of America. 114, 4, p. E496-E505  Abstract [All authors]
296.
Isaac R., Goldstein I., Furth N. et al. (2017) Cell Death and Differentiation. 24, 1, p. 132-143  Abstract [All authors]

2016

295.
Simerzin A., Zorde-Khvalevsky E., Rivkin M. et al. (2016) Hepatology. 64, 5, p. 1623-1636  Abstract [All authors]
294.
Aylon Y. & Oren M. (2016) Cell cycle (Georgetown, Tex.). 15, 17, p. 2248-2255  Abstract
293.
Oren M. & Kotler E. (2016) Nature Cell Biology. 18, 8, p. 833-835  Abstract
292.
Yaeger R., Shah M. A., Miller V. A. et al. (2016) Gastroenterology. 151, 2, p. 278-287.e6  Abstract [All authors]
291.
Stock K., Estrada M. F., Vidic S. et al. (2016) Scientific Reports. 6, 28951.  Abstract [All authors]
290.
Aylon Y. & Oren M. (2016) Cold Spring Harbor perspectives in medicine. 6, 10, a026328.  Abstract
289.
Orsolic I., Jurada D., Pullen N., Oren M., Eliopoulos A. G. & Volarevic S. (2016) Seminars in Cancer Biology. 37-38, p. 36-50  Abstract
288.
Barbier M., Jaensch S., Cornelissen F. et al. (2016) PLoS ONE. 11, 6, e0156942.  Abstract [All authors]
287.
Aylon Y., Gershoni A., Rotkopf R. et al. (2016) GENES & DEVELOPMENT. 30, 7, p. 786-797  Abstract [All authors]
286.
Tal P., Eizenberger S., Cohen E., Goldfinger N., Pietrokovski S., Oren M. & Rotter V. (2016) Oncotarget. 7, 11, p. 11817-11837  Abstract
285.
Tarcic O., Pateras I. S., Cooks T. et al. (2016) Cell Reports. 14, 6, p. 1462-1476  Abstract [All authors]
284.
Hoffman Y., Bublik D. R., Ugalde A. P., Elkon R., Biniashvili T., Agami R., Oren M. & Pilpel Y. (2016) PLoS Genetics. 12, 2, e1005879.  Abstract
283.
Oren M., Tal P. & Rotter V. (2016) AGING-US. 8, 6, p. 1159-1160  Abstract

2015

282.
Golomb L., Sagiv A., Pateras I., Maly A., Krizhanovsky V., Gorgoulis V., Oren M. & Ben-Yehuda A. (2015) Cell Death and Differentiation. 22, 11, p. 1764-1774  Abstract
281.
Blume C. J., Hotz-Wagenblatt A., Hüllein J. et al. (2015) Leukemia. 29, 10, p. 2015-2023  Abstract [All authors]
280.
Harel S., Ben-Moshe N., Aylon Y. et al. (2015) Cell Death and Differentiation. 22, p. 1328-1340  Abstract [All authors]
279.
Oren M., Damalas A., Gottlieb T. et al. (2015) Biochemical Pharmacology. 96, 4, p. 369 12280.  Abstract [All authors]
278.
Pribluda A., Elyada E., Wiener Z. et al. (2015) Cancer Cell. 27, 6, p. 877-878  Abstract
[All authors]
277.
Fuchs G., Voichek Y., Rabani M., Benjamin S., Gilad S., Amit I. & Oren M. (2015) Nature protocols. 10, 4, p. 605-618  Abstract
276.
Furth N., Bossel Ben-Moshe B. N., Pozniak Y., Porat Z., Geiger T., Domany E., Aylon Y. & Oren M. (2015) Genes and Development. 29, p. 2325-2330  Abstract

2014

275.
Lasry A., Aran D., Zinger A. et al. (2014) Cytokine. 70, 1, p. 22-22  Abstract
[All authors]
274.
Fuchs G., Hollander D., Voichek Y., Ast G. & Oren M. (2014) Genome Research. 24, 10, p. 1572-1583  Abstract
273.
Golomb L., Volarevic S. & Oren M. (2014) FEBS Letters. 588, 16, p. 2571-2579  Abstract
272.
Fuchs G. & Oren M. (2014) Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 1839, 8, p. 694-701  Abstract
271.
Cooks T., Harris C. & Oren M. (2014) Carcinogenesis. 35, 8, p. 1680-1690  Abstract
270.
Weilbacher A., Gutekunst M., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2014) Cell Death & Disease. 5, 7, e1318.  Abstract
269.
Oren M. (2014) European Journal of Cancer. 50, p. VII  Abstract
268.
Hoffman Y., Pilpel Y. & Oren M. (2014) Journal of Molecular Cell Biology. 6, 3, p. 192-197  Abstract
267.
Aylon Y., Sarver A., Tovy A., Ainbinder E. & Oren M. (2014) Cell Death and Differentiation. 21, 4, p. 624-633  Abstract
266.
Hoffman Y., Bublik D. R., Pilpel Y. & Oren M. (2014) Cell Death and Differentiation. 21, 2, p. 302-309  Abstract
265.
Weingarten-Gabbay S., Khan D., Liberman N., Yoffe Y., Bialik S., Das S., Oren M. & Kimchi A. (2014) Oncogene. 33, 5, p. 611-618  Abstract
264.
Shtivelman E., Davies M. A., Hwu P., Yang J., Lotem M., Oren M., Flaherty K. T. & Fisher D. E. (2014) Oncotarget. 5, 7, p. 1701-1752  Abstract
263.
Fuchs G., Voichek Y., Benjamin S., Gilad S., Amit I. & Oren M. (2014) GENOME BIOLOGY. 15, 5, p. R69  Abstract

2013

262.
Golomb L. & Oren M. (2013) Cell Death and Differentiation. 20, 11, p. 1442-1443  Abstract
261.
Fausti F., Di Agostino A. S., Cioce M. et al. (2013) Cell Death and Differentiation. 20, 11, p. 1498-1509  Abstract
[All authors]
260.
Pribluda A., Elyada E., Wiener Z. et al. (2013) Cancer Cell. 24, 2, p. 242-256  Abstract [All authors]
259.
Cooks T., Pateras I. S., Tarcic O. et al. (2013) Cancer Cell. 23, 5, p. 634-646  Abstract [All authors]
258.
Hoffman Y., Dahary D., Bublik D. R., Oren M. & Pilpel Y. (2013) Bioinformatics. 29, 7, p. 894-902  Abstract
257.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013)  Abstract
256.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Bedke J., Kruck S., Oren M., Aulitzky W. E. & Van Der Kuip H. (2013) Cancer Research. 73, 5, p. 1460-1469  Abstract
255.
Suzuki H., Yabuta N., Okada N., Torigata K., Aylon Y., Oren M. & Nojima H. (2013) Journal of Cell Science. 126, 19, p. 4358-4368  Abstract
254.
Shema E., Nikolov M., Haj-Yahya M. et al. (2013) Cell Reports. 4, 3, p. 601-608  Abstract [All authors]

2012

253.
Bursać S., Brdovčak M. C., Pfannkuchen M. et al. (2012) Proceedings of the National Academy of Sciences of the United States of America. 109, 50, p. 20467-20472  Abstract [All authors]
252.
Hornung G., Bar-Ziv R., Rosin D., Tokuriki N., Tawfik D., Oren M. & Barkai N. (2012) Genome Research. 22, 12, p. 2409-2417  Abstract
251.
Schmid J. O., Dong M., Haubeiss S. et al. (2012) Cancer Research. 72, 22, p. 5824-5832  Abstract
[All authors]
250.
Haj-Yahya M., Eltarteer N., Ohayon S., Shema E., Kotler E., Oren M. & Brik A. (2012) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 51, 46, p. 11535-11539  Abstract
249.
Fuchs G., Shema E., Vesterman R. et al. (2012) Molecular Cell. 46, 5, p. 662-673  Abstract [All authors]
248.
Hornung G., Oren M. & Barkai N. (2012) Molecular Cell. 46, 3, p. 362-368  Abstract
247.
Bublik D. R. & Oren M. (2012) EMBO Reports. 13, 4, p. 282-283  Abstract
246.
Zwang Y., Oren M. & Yarden Y. (2012) Cancer Research. 72, 5, p. 1051-1054  Abstract
245.
Blandino G., Deppert W., Hainaut P., Levine A., Lozano G., Olivier M., Rotter V., Wiman K. & Oren M. (2012) Cell Death and Differentiation. 19, 1, p. 180-183  Abstract
244.
Golomb L., Bublik D. R., Wilder S., Nevo R., Kiss V., Grabusic K., Volarevic S. & Oren M. (2012) Molecular Cell. 45, 2, p. 222-232  Abstract

2011

243.
Golomb L. & Oren M. (2011) Cancer Cell. 20, 3, p. 283-284  Abstract
242.
Furth N. & Oren M. (2011) Cell Cycle. 10, 18, p. 3054-3055  Abstract
241.
Shiloh Y., Shema E., Moyal L. & Oren M. (2011) FEBS Letters. 585, 18, p. 2795-2802  Abstract
240.
Aylon Y. & Oren M. (2011) Molecular Oncology. 5, 4, p. 315-323  Abstract
239.
Tarocchi M., Hannivoort R., Hoshida Y. et al. (2011) Hepatology. 54, 2, p. 522-531  Abstract
[All authors]
238.
Shema E., Oren M. & Minsky N. (2011) Methods. 54, 3, p. 326-330  Abstract
237.
Dell'Orso S., Fontemaggi G., Stambolsky P. et al. (2011) Omics-A Journal Of Integrative Biology. 15, 5, p. 305-312  Abstract [All authors]
236.
Shema E., Kim J., Roeder R. G. & Oren M. (2011) Molecular Cell. 42, 4, p. 477-488  Abstract
235.
Zwang Y., Sas-Chen A., Drier Y. et al. (2011) Molecular Cell. 42, 4, p. 524-535  Abstract [All authors]
234.
Elyada E., Pribluda A., Goldstein R. E. et al. (2011) Nature. 470, 7334, p. 409-413  Abstract [All authors]
233.
Aylon Y. & Oren M. (2011) Current opinion in genetics & development. 21, 1, p. 86-92  Abstract
232.
Okada N., Yabuta N., Suzuki H., Aylon Y., Oren M. & Nojima H. (2011) Journal of Cell Science. 124, 1, p. 57-67  Abstract
231.
Goldstein I., Marcel V., Olivier M., Oren M., Rotter V. & Hainaut P. (2011) Cancer Gene Therapy. 18, 1, p. 2-11  Abstract
230.
Gutekunst M., Oren M., Weilbacher A., Dengler M. A., Markwardt C., Thomale J., Aulitzky W. E. & van der Kuip H. (2011) PLoS ONE. 6, 4, e19198.  Abstract

2010

229.
Addadi Y., Moskovits N., Granot D., Lozano G., Carmi Y., Apte R. N., Neeman M. & Oren M. (2010) Cancer Research. 70, 23, p. 9650-9658  Abstract
228.
Aylon Y., Ofir-Rosenfeld Y., Yabuta N., Lapi E., Nojima H., Lu X. & Oren M. (2010) GENES & DEVELOPMENT. 24, 21, p. 2420-2429  Abstract
227.
Nili E. L., Field Y., Lubling Y., Widom J., Oren M. & Segal E. (2010) Genome Research. 20, 10, p. 1361-1368  Abstract
226.
Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z. & Oren M. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 43, p. 18511-18516  Abstract
225.
Shalgi R., Pilpel Y. & Oren M. (2010) Trends in Genetics. 26, 6, p. 253-259  Abstract
224.
Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 5, p. 523  Abstract [All authors]
223.
Schilling T., Kairat A., Melino G., Krammer P. H., Stremmel W., Oren M. & Müller M. (2010) Biochemical and Biophysical Research Communications. 394, 3, p. 817-823  Abstract
222.
Oren M. & Cooks T. (2010) Cell Cycle. 9, 6, p. 1025-1030  Abstract
221.
Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 3, p. 273-285  Abstract [All authors]
220.
Christoffersen N. R., Shalgi R., Frankel L. B. et al. (2010) Cell Death and Differentiation. 17, 2, p. 236-245  Abstract [All authors]
219.
Oren M. & Rotter V. (2010) Cold Spring Harbor perspectives in biology. 2, 2, p. a001107  Abstract
218.
Bar J., Moskovits N. & Oren M. (2010) SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 21, 1, p. 47-54  Abstract

2009

217.
Skorta I., Oren M., Markwardt C., Gutekunst M., Aulitzky W. E. & Van Der Kuip H. (2009) Cancer Research. 69, 24, p. 9337-9345  Abstract
216.
Aylon Y., Yabuta N., Besserglick H., Buganim Y., Rotter V., Nojima H. & Oren M. (2009) Oncogene. 28, 50, p. 4469-4479  Abstract
215.
Levine A. J. & Oren M. (2009) Nature Reviews Cancer. 9, 10, p. 749-758  Abstract
214.
Schilling T., Schleithoff E. S., Kairat A., Melino G., Stremmel W., Oren M., Krammer P. H. & Müller M. (2009) Biochemical and Biophysical Research Communications. 387, 2, p. 399-404  Abstract
213.
Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate
Shalgi R., Brosh R., Oren M., Pilpel Y. & Rotter V. (2009) AGING-US. 1, 9, p. 762-770  Abstract
212.
Bar J., Feniger-Barish R., Lukashchuk N. et al. (2009) Oncogene. 28, 6, p. 933-936  Abstract [All authors]
211.
Pirngruber J., Shchebet A., Schreiber L. et al. (2009) EMBO Reports. 10, 8, p. 894-900  Abstract [All authors]
210.
Lavelin I., Beer A., Kam Z., Rotter V., Oren M., Navon A. & Geiger B. (2009) PLoS ONE. 4, 12, e8503.  Abstract

2008

209.
Ofir-Rosenfeld Y., Boggs K., Michael D., Kastan M. B. & Oren M. (2008) Molecular Cell. 32, 2, p. 180-189  Abstract
208.
Shema E., Tirosh I., Aylon Y. et al. (2008) GENES & DEVELOPMENT. 22, 19, p. 2664-2676  Abstract [All authors]
207.
Finkin S., Aylon Y., Anzi S., Oren M. & Shaulian E. (2008) Oncogene. 27, 32, p. 4411-4421  Abstract
206.
Bossi G., Marampon F., Maor-Aloni R., Zani B., Rotter V., Oren M., Strano S., Blandino G. & Sacchi A. (2008) Cell Cycle. 7, 12, p. 1870-1879  Abstract
205.
Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M. & Tanaka N. (2008) Proceedings of the National Academy of Sciences of the United States of America. 105, 12, p. 4838-4843  Abstract
204.
Minsky N., Shema E., Field Y., Schuster M., Segal E. & Oren M. (2008) Nature Cell Biology. 10, 4, p. 483-488  Abstract
203.
Brosh R., Shalgi R., Liran A. et al. (2008) Molecular Systems Biology. 4, 229.  Abstract
[All authors]

2007

202.
Lantner F., Starlets D., Gore Y. et al. (2007) Blood. 110, 13, p. 4303-4311  Abstract
[All authors]
201.
Raver-Shapira N. & Oren M. (2007) Cell Cycle. 6, 21, p. 2656-2661  Abstract
200.
Lu X., Ma O., Nguyen T. A., Jones S. N., Oren M. & Donehower L. A. (2007) Cancer Cell. 12, 4, p. 342-354  Abstract
199.
Reef S., Shifman O., Oren M. & Kimchi A. (2007) Oncogene. 26, 46, p. 6677-6683  Abstract
198.
Aylon Y. & Oren M. (2007) Cell. 130, 4, p. 597-600  Abstract
197.
Shalgi R., Lieber D., Oren M. & Pilpel Y. (2007) PLoS Computational Biology. 3, 7, p. 1291-1304  Abstract
196.
Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z. & Oren M. (2007) Molecular Cell. 26, 5, p. 731-743  Abstract
195.
Weisz L., Oren M. & Rotter V. (2007) Oncogene. 26, 15, p. 2202-2211  Abstract
194.
Weisz L., Damalas A., Liontos M. et al. (2007) Cancer Research. 67, 6, p. 2396-2401  Abstract [All authors]
193.
Oren M. & Bartek J. (2007) Cell. 128, 5, p. 826-828  Abstract
192.
Shmueli A. & Oren M. (2007) Molecular Cell. 25, 6, p. 794-796  Abstract

2006

191.
Stambolsky P., Weisz L., Shats I., Klein Y. A., Goldfinger N., Oren M. & Rotter V. (2006) Cell Death and Differentiation. 13, 12, p. 2140-2149  Abstract
190.
Moskovits N., Kalinkovich A., Bar J., Lapidot T. & Oren M. (2006) Cancer Research. 66, 22, p. 10671-10676  Abstract
189.
Oren M. (2006) Ejc Supplements. 4, 12, p. 76-76  Abstract
188.
Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H. & Oren M. (2006) Genes and Development. 20, 19, p. 2687-2700  Abstract
187.
Rentsch C. A., Germann M., Wetterwald A. et al. (2006) European Urology Supplements. 5, 14, p. 790-790  Abstract
[All authors]
186.
Reef S., Zalckvar E., Shifman O., Bialik S., Sabanay H., Oren M. & Kimchi A. (2006) Molecular Cell. 22, 4, p. 463-475  Abstract
185.
Avkin S., Sevilya Z., Toube L., Geacintov N., Chaney S., Oren M. & Livneh Z. (2006) Molecular Cell. 22, 3, p. 407-413  Abstract
184.
Kogan I., Goldfinger N., Milyavsky M. et al. (2006) Cancer Research. 66, 7, p. 3531-3540  Abstract
[All authors]
183.
Margalit O., Amram H., Amariglio N. et al. (2006) Blood. 107, 4, p. 1599-1607  Abstract [All authors]
182.
Zalcenstein A., Weisz L., Stambolsky P., Bar J., Rotter V. & Oren M. (2006) Oncogene. 25, 3, p. 359-369  Abstract

2005

181.
Bar J., Lukaschuk N., Zalcenstein A., Wilder S., Seger R. & Oren M. (2005) Cell Death and Differentiation. 12, 12, p. 1578-1587  Abstract
180.
Muller M., Schilling T., Sayan A. et al. (2005) Cell Death and Differentiation. 12, 12, p. 1564-1577  Abstract [All authors]
179.
Shmueli A. & Oren M. (2005) Cell. 121, 7, p. 963-965  Abstract
178.
Gressner O., Schilling T., Lorenz K. et al. (2005) EMBO Journal. 24, 13, p. 2458-2471  Abstract [All authors]
177.
Oberst A., Rossi M., Salornoni P., Pandolfi P., Oren M., Melino G. & Bernassola F. (2005) Biochemical and Biophysical Research Communications. 331, 3, p. 707-712  Abstract
176.
Hershko T., Chaussepied M., Oren M. & Ginsberg D. (2005) Cell Death and Differentiation. 12, 4, p. 377-383  Abstract
175.
Wohlbold L., van der Kuip d. K. H., Moehring A., Granot G., Oren M., Vornlocher H. & Aulitzky W. (2005) Leukemia. 19, 2, p. 290-292  Abstract
174.
Damalas A., Weis L., Nordgard S. et al. (2005) Breast Cancer Research. 7, p. S53-S53  Abstract
[All authors]

2004

173.
Weisz L., Zalcenstein A., Stambolsky P., Cohen Y., Goldfinger N., Oren M. & Rotter V. (2004) Cancer Research. 64, 22, p. 8318-8327  Abstract
172.
Minsky N. & Oren M. (2004) Molecular Cell. 16, 4, p. 631-639  Abstract
171.
Daniely Y., Liao G., Dixon D., Linnoila R. I., Lori A., Randell S. H., Oren M. & Jetten A. M. (2004) American Journal Of Physiology-Cell Physiology. 287, 1 56-1, p. C171-C181  Abstract
170.
Levina E., Oren M. & Ben-Ze'ev A. (2004) Oncogene. 23, 25, p. 4444-4453  Abstract
169.
Bar J., Cohen-Noyman E., Geiger B. & Oren M. (2004) Oncogene. 23, 12, p. 2128-2137  Abstract
168.
Fiucci G., Beaucourt S., Duflaut D. et al. (2004) Proceedings of the National Academy of Sciences of the United States of America. 101, 10, p. 3510-3515  Abstract
[All authors]
167.
Wang X., Taplick J., Geva N. & Oren M. (2004) FEBS Letters. 561, 1-3, p. 195-201  Abstract
166.
Shmueli A. & Oren M. (2004) Molecular Cell. 13, 1, p. 4-5  Abstract

2003

165.
Zalcenstein A., Stambolsky P., Weisz L., Muller M., Wallach D., Goncharov T., Krammer P., Rotter V. & Oren M. (2003) Oncogene. 22, 36, p. 5667-5676  Abstract
164.
Wang X., Zalcenstein A. & Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 468-476  Abstract
163.
Ofek P., Ben-Meir D., Kariv-Inbal Z., Oren M. & Lavi S. (2003) Journal of Biological Chemistry. 278, 16, p. 14299-14305  Abstract
162.
Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 431-442  Abstract
161.
Passer B., Nancy-Portebois V., Amzallag N. et al. (2003) Proceedings of the National Academy of Sciences of the United States of America. 100, 5, p. 2284-2289  Abstract [All authors]
160.
Michael D. & Oren M. (2003) Seminars in Cancer Biology. 13, 1, p. 49-58  Abstract
159.
Nuclear factor-κB protects the liver against genotoxic stress and functions independently of p53
Lavon I., Pikarsky E., Gutkovich E., Goldberg I., Bar J., Oren M. & Ben-Neriah Y. (2003) Cancer Research. 63, 1, p. 25-30  Abstract

2002

158.
Blandert G., Zalle N., Daniely Y., Taplick J., Gray M. D. & Oren M. (2002) Journal of Biological Chemistry. 277, 52, p. 50934-50940  Abstract
157.
Oren M., DAMALAS A., GOTTLIEB T. et al. (2002) Annals of the New York Academy of Sciences. 973, 1, p. 374-383  Abstract
[All authors]
156.
Balass M., Kalef E., Maya R., Wilder S., Oren M. & Katchalski-Katzir E. (2002) Peptides. 23, 10, p. 1719-1725  Abstract
155.
Shtutman M., Zhurinsky J., Oren M., Levina E. & Ben-Ze'ev A. (2002) Cancer Research. 62, 20, p. 5947-5954  Abstract
154.
Goldberg Z., Vogt Sionov S. R., Berger M., Zwang Y., Perets R., Van Etten E. R., Oren M., Taya Y. & Haupt Y. (2002) EMBO Journal. 21, 14, p. 3715-3727  Abstract
153.
Strano S., Fontemaggi G., Costanzo A. et al. (2002) Journal of Biological Chemistry. 277, 21, p. 18817-18826  Abstract [All authors]
152.
Wang X., Michael D., De Murcia G. & Oren M. (2002) Journal of Biological Chemistry. 277, 18, p. 15697-15702  Abstract
151.
Folberg-Blum A., Sapir A., Shilo B. & Oren M. (2002) Oncogene. 21, 15, p. 2413-2417  Abstract
150.
Gottlieb T., Leal J., Seger R., Taya Y. & Oren M. (2002) Oncogene. 21, 8, p. 1299-1303  Abstract
149.
Michael D. & Oren M. (2002) Current opinion in genetics & development. 12, 1, p. 53-59  Abstract
148.
Courtois S., Verhaegh G., North S., Luciani M., Lassus P., Hibner U., Oren M. & Hainaut P. (2002) Oncogene. 21, 44, p. 6722-6728  Abstract

2001

147.
Susini L., Passer B., Amzallag-Elbaz N. et al. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 26, p. 15067-15072  Abstract
[All authors]
146.
Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells
Goetz A., van der Kuip d. K. H., Maya R., Oren M. & Aulitzky W. (2001) Cancer Research. 61, 20, p. 7635-7641  Abstract
145.
Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A. & Oren M. (2001) EMBO Journal. 20, 17, p. 4912-4922  Abstract
144.
Strano S., Munarriz E., Rossi M. et al. (2001) Journal of Biological Chemistry. 276, 18, p. 15164-15173  Abstract [All authors]
143.
Maya R., Balass M., Kim S. et al. (2001) GENES & DEVELOPMENT. 15, 9, p. 1067-1077  Abstract [All authors]
142.
Oren M. (2001) Experimental Cell Research. 264, 1, p. 1  Abstract
141.
The p53 saga: the good, the bad, and the dead.
Oren M. (2001) Harvey lectures. 97, p. 57-82  Abstract
140.
Sadot E., Geiger B., Oren M. & Ben-Ze'ev A. (2001) Molecular and Cellular Biology. 21, 20, p. 6768-6781  Abstract

2000

139.
Reinstein E., Scheffner M., Oren M., Ciechanover A. & Schwartz A. (2000) Oncogene. 19, 51, p. 5944-5950  Abstract
138.
Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M. & McCormick F. (2000) Cell. 103, 2, p. 321-330  Abstract
137.
Bar-Or R., Maya R., Segel L., Alon U., Levine A. & Oren M. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 21, p. 11250-11255  Abstract
136.
Strano S., Munarriz E., Rossi M. et al. (2000) Journal of Biological Chemistry. 275, 38, p. 29503-29512  Abstract [All authors]
135.
Maya R. & Oren M. (2000) Oncogene. 19, 28, p. 3213-3215  Abstract
134.
Amson R., Lassalle J., Halley H. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 10, p. 5346-5350  Abstract
[All authors]
133.
de Rozieres R. S., Maya R., Oren M. & Lozano G. (2000) Oncogene. 19, 13, p. 1691-1697  Abstract
132.
Blander G., Zalle N., Leal J., Bar-Or R., Yu C. & Oren M. (2000) FASEB Journal. 14, 14, p. 2138-2140  Abstract

1999

131.
Oren M. (1999) Journal of Biological Chemistry. 274, 51, p. 36031-36034  Abstract
130.
Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y. & Shkedy D. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 26, p. 14973-14977  Abstract
129.
Blander G., Kipnis J., Leal J., Yu C., Schellenberg G. & Oren M. (1999) Journal of Biological Chemistry. 274, 41, p. 29463-29469  Abstract
128.
Elkeles A. & Oren M. (1999) Molecular Medicine Today. 5, 8, p. 334-335  Abstract
127.
Roperch J., Lethrone F., Prieur S. et al. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 14, p. 8070-8073  Abstract
[All authors]
126.
Damalas A., Ben-Ze'ev A., Simcha I., Shtutman N., Leal J., Zhurinsky J., Geiger B. & Oren M. (1999) EMBO Journal. 18, 11, p. 3054-3063  Abstract
125.
Hot papers - Cancer research - Mdm2 promotes the rapid degradation of p53 by Y. Haupt, R. Maya, A. Kazaz, M. Oren and Regulation of p53 stability by Mdm2 by M.H.G. Kubbutat, S.N. Jones, K.H. Vousden - Comments
Oren M. & Vousden K. (1999) Scientist. 13, 12, p. 11-11  Abstract
124.
Agami R., Blandino G., Oren M. & Shaul Y. (1999) Nature. 399, 6738, p. 809-812  Abstract
123.
Unger T., Sionov R., Moallem E., Yee C., Howley P., Oren M. & Haupt Y. (1999) Oncogene. 18, 21, p. 3205-3212  Abstract
122.
MDM2 suppresses p73 function without promoting p73 degradation
Zeng X., Chen L., Jost C. et al. (1999) Molecular and Cellular Biology. 19, 5, p. 3257-3266  Abstract [All authors]
121.
Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R., Lozano G., Oren M. & Haupt Y. (1999) EMBO Journal. 18, 7, p. 1805-1814  Abstract
120.
Elkeles A., Juven-Gershon T., Israeli D., Wilder S., Zalcenstein A. & Oren M. (1999) Molecular and Cellular Biology. 19, 4, p. 2594-2600  Abstract
119.
Sionov R., Moallem E., Berger M., Kazaz A., Gerlitz O., Ben-Neriah Y., Oren M. & Haupt Y. (1999) Journal of Biological Chemistry. 274, 13, p. 8371-8374  Abstract
118.
Oren M. & Rotter V. (1999) Cellular and Molecular Life Sciences. 55, 1, p. 9-11  Abstract
117.
Juven-Gershon T. & Oren M. (1999) Molecular Medicine. 5, 2, p. 71-83  Abstract
116.
Blandino G., Levine A. & Oren M. (1999) Oncogene. 18, 2, p. 477-485  Abstract

1998

115.
Muller M., Wilder S., Bannasch D. et al. (1998) Journal of Experimental Medicine. 188, 11, p. 2033-2045  Abstract [All authors]
114.
Wang Y., Blandino G., Oren M. & Givol D. (1998) Oncogene. 17, 15, p. 1923-1930  Abstract
113.
Yardley G., Zauberman A., Oren M. & Jackson P. (1998) FEBS Letters. 430, 3, p. 171-175  Abstract
112.
Gottlieb E. & Oren M. (1998) EMBO Journal. 17, 13, p. 3587-3596  Abstract
111.
Roperch J., Alvaro V., Prieur S. et al. (1998) Nature Medicine. 4, 7, p. 835-838  Abstract
[All authors]
110.
Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y. & Oren M. (1998) Molecular and Cellular Biology. 18, 7, p. 3974-3982  Abstract
109.
Hosokawa K., Aharoni D., Dantes A. et al. (1998) Endocrinology. 139, 11, p. 4688-4700  Abstract
[All authors]
108.
Ori A., Zauberman A., Doitsh G., Paran N., Oren M. & Shaul Y. (1998) EMBO Journal. 17, 2, p. 544-553  Abstract
107.
Oren M. (1998) Nature. 391, 6664, p. 233-234  Abstract

1997

106.
Gottlieb T. M. & Oren M. (1997) Seminars in Cancer Biology. 8, 5, p. 359-368  Abstract
105.
Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R., Telerman A. & Oren M. (1997) EMBO Journal. 16, 14, p. 4384-4392  Abstract
104.
Haupt Y., Maya R., Kazaz A. & Oren M. (1997) Nature. 387, 6630, p. 296-299  Abstract
103.
Ruaro E., Collavin L., DelSal G., Haffner R., Oren M., Levine A. & Schneider C. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 9, p. 4675-4680  Abstract
102.
Gottlieb E., Haffner R., King A., Asher G., Gruss P., Lonai P. & Oren M. (1997) EMBO Journal. 16, 6, p. 1381-1390  Abstract
101.
Hansen R. & Oren M. (1997) Current opinion in genetics & development. 7, 1, p. 46-51  Abstract
100.
Shaulian E., Resnitzky D., Shifman O., Blandino G., Amsterdam A., Yayon A. & Oren M. (1997) Oncogene. 15, 22, p. 2717-2725  Abstract
99.
Friedman S., Shaulian E., Littlewood T., Resnitzky D. & Oren M. (1997) Oncogene. 15, 1, p. 63-70  Abstract
97.
Zauberman A., Oren M. & Zipori D. (1997) Oncogene. 15, 14, p. 1705-1711  Abstract

1996

96.
p53-mediated apoptosis: mechanisms and regulation.
Haupt Y. & Oren M. (1996) Behring Institute Mitteilungen. 97, p. 32-59  Abstract
95.
Nemani M., LinaresCruz G., BruzzoniGiovanelli H. et al. (1996) Proceedings of the National Academy of Sciences of the United States of America. 93, 17, p. 9039-9042  Abstract
[All authors]
94.
Bowman T., Symonds H., Gu L., Yin C., Oren M. & Van Dyke T. (1996) GENES & DEVELOPMENT. 10, 7, p. 826-835  Abstract
93.
Haupt Y., Barak Y. & Oren M. (1996) EMBO Journal. 15, 7, p. 1596-1606  Abstract
92.
Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells
Gottlieb E., Lindner S. & Oren M. (1996) Cell Growth and Differentiation. 7, 3, p. 301-310  Abstract
91.
Oren M. & Prives C. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1288, 3, p. R13-R19  Abstract
90.
Friedlander P., Haupt Y., Prives C. & Oren M. (1996) Molecular and Cellular Biology. 16, 9, p. 4961-4971  Abstract
89.
Gottlieb T. M. & Oren M. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1287, 2-3, p. 77-102  Abstract
88.
Rowan S., Ludwig R., Haupt Y., Bates S., Lu X., Oren M. & Vousden K. (1996) EMBO Journal. 15, 4, p. 827-838  Abstract
87.
Tanaka N., Ishihara M., Lamphier M. et al. (1996) Nature. 382, 6594, p. 816-818  Abstract
[All authors]
86.
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
Bacus S., Yarden Y., Oren M. et al. (1996) Oncogene. 12, 12, p. 2535-2547  Abstract
[All authors]
85.
Eizenberg O., FaberElman A., Gottlieb E., Oren M., Rotter V. & Schwartz M. (1996) Molecular and Cellular Biology. 16, 9, p. 5178-5185  Abstract
84.
p53-Mediated apoptosis - Regulatory and mechanistic aspects
Haupt Y., Rowan S., Shaulian E., Gottlieb E., YonishRouach E., Vousden K. & Oren M. (1996) Cancer Genes: Functional Aspects. 7, p. 83-101  Abstract

1995

83.
HIEBERT S., PACKHAM G., STROM D., HAFFNER R., Oren M., ZAMBETTI G. & CLEVELAND J. (1995) Molecular and Cellular Biology. 15, 12, p. 6864-6874  Abstract
82.
Cancer: The translation of advances in basic science to human therapy. 22-27 July, 1995 - La fondation des Treilles, Tourtour, France - Discussion
Harlow E., Tlsty T., Courtneidge S. et al. (1995) Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences. 318, 11, p. 1173-1179  Abstract
[All authors]
81.
Malcomson R. D., Oren M., Wyllie A. H. & Harrison D. J. (1995) British Journal of Cancer. 72, 4, p. 952-957  Abstract
80.
HAUPT Y., ROWAN S., SHAULIAN E., VOUSDEN K. & Oren M. (1995) GENES & DEVELOPMENT. 9, 17, p. 2170-2183  Abstract
79.
Zauberman A., FLUSBERG D., HAUPT Y., Barak Y. & Oren M. (1995) Nucleic Acids Research. 23, 14, p. 2584-2592  Abstract
78.
IDENTIFICATION OF P53 TARGET GENES THROUGH IMMUNE SELECTION OF GENOMIC DNA - THE CYCLIN-G GENE CONTAINS 2 DISTINCT P53 BINDING-SITES
Zauberman A., LUPO A. & Oren M. (1995) Oncogene. 10, 12, p. 2361-2366  Abstract
77.
AHARONI D., Dantes A., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 271-282  Abstract
76.
KERENTAL I., SUH B., Dantes A., LINDNER S., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 283-295  Abstract
75.
P53-MEDIATED APOPTOSIS IN HELA-CELLS CAN BE OVERCOME BY EXCESS PRB
HAUPT Y., ROWAN S. & Oren M. (1995) Oncogene. 10, 8, p. 1563-1571  Abstract
74.
EIZENBERG O., FABER-ELMAN A., GOTTLIEB E., Oren M., Rotter V. & Schwartz M. (1995) EMBO Journal. 14, 6, p. 1136-1144  Abstract
73.
Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma
Corvi R., Savelyeva L., Breit S., Wenzel A., Handgretinger R., Barak J., Oren M., Amler L. & Schwab M. (1995) Oncogene. 10, 6, p. 1081-1086  Abstract
72.
TRANSCRIPTIONAL REPRESSION BY THE C-TERMINAL DOMAIN OF P53
SHAULIAN E., HAVIV I., Shaul Y. & Oren M. (1995) Oncogene. 10, 4, p. 671-680  Abstract
71.
Haffner R. & Oren M. (1995) Current Opinion in Genetics and Development. 5, 1, p. 84-90  Abstract
70.
STUART E., HAFFNER R., Oren M. & GRUSS P. (1995) EMBO Journal. 14, 22, p. 5638-5645  Abstract

1994

69.
Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2
CIECHANOVER A., SHKEDY D., Oren M. & BERCOVICH B. (1994) Journal of Biological Chemistry. 269, 13, p. 9582-9589  Abstract
68.
GOTTLIEB E., HAFFNER R., VON RUDEN T., WAGNER E. & Oren M. (1994) EMBO Journal. 13, 6, p. 1368-1374  Abstract
67.
Barak Y., GOTTLIEB E., JUVENGERSHON T. & Oren M. (1994) GENES & DEVELOPMENT. 8, 15, p. 1739-1749  Abstract
66.
Barak Y., LUPO A., Zauberman A., JUVEN T., ALONIGRINSTEIN R., GOTTLIEB E., Rotter V. & Oren M. (1994) Cold Spring Harbor Symposia on Quantitative Biology. 59, p. 225-235  Abstract
65.
WILD-TYPE P(53) ACTIVITY CONTRIBUTES TO DEPENDENCE ON HEMATOPOIETIC SURVIVAL FACTORS
GOTTLIEB E., HAFFNER R., YONISHROUACH E., VONRUDEN T., WAGNER E. & Oren M. (1994) Apoptosis. 5, p. 31-45  Abstract
64.
Relationship of p53 to the control of apoptotic cell death
Oren M. (1994) Seminars in Cancer Biology. 5, 3, p. 221-227  Abstract

1993

63.
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene
JUVEN T., Barak Y., Zauberman A., GEORGE D. & Oren M. (1993) Oncogene. 8, 12, p. 3411-3416  Abstract
62.
Levy N., YONISHROUACH E., Oren M. & Kimchi A. (1993) Molecular and Cellular Biology. 13, 12, p. 7942-7952  Abstract
61.
Telerman A., TUYNDER M., DUPRESSOIR T., ROBAYE B., SIGAUX F., SHAULIAN E., Oren M., ROMMELAERE J. & AMSON R. (1993) Proceedings of the National Academy of Sciences of the United States of America. 90, 18, p. 8702-8706  Abstract
60.
SHAULIAN E., Zauberman A., MILNER J., DAVIES E. & Oren M. (1993) EMBO Journal. 12, 7, p. 2789-2797  Abstract
59.
Zauberman A., Barak Y., RAGIMOV N., Levy N. & Oren M. (1993) EMBO Journal. 12, 7, p. 2799-2808  Abstract
58.
ALONI, YOSEF - (1936-1993) - OBITUARY
Oren M. (1993) Oncogene. 8, 6, p. 1405-1405  Abstract
57.
Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif
RAGIMOV N., KRAUSKOPF A., NAVOT N., Rotter V., Oren M. & ALONI Y. (1993) Oncogene. 8, 5, p. 1183-1193  Abstract
56.
p53-mediated cell death: Relationship to cell cycle control
YONISHROUACH E., GRUNWALD D., Wilder S., Kimchi A., MAY E., LAWRENCE J., MAY P. & Oren M. (1993) Molecular and Cellular Biology. 13, 3, p. 1415-1423  Abstract
55.
Barak Y., JUVEN T., HAFFNER R. & Oren M. (1993) EMBO Journal. 12, 2, p. 461-468  Abstract
54.
Yonish-Rouach E., Ginsberg D. & Oren M. (1993) Programmed Cell Death. p. 187-201  Abstract
53.
MECHANISMS OF ACTION OF P53
BARAK Y., GINSBERG D., MICHAEL D., RAGIMOV N., SHAULIAN E., YONISHROUACH E., ZAUBERMAN A., ALONI Y. & OREN M. (1993) PHARMACOLOGY OF CELL DIFFERENTIATION. Rifkind RA.(eds.). p. 129-141 (trueINTERNATIONAL CONGRESS SERIES).  Abstract

1992

52.
Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA binding
SHAULIAN E., Zauberman A., GINSBERG D. & Oren M. (1992) Molecular and Cellular Biology. 12, 12, p. 5581-5592  Abstract
51.
The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.
Yehiely F. & Oren M. (1992) Molecular Cancer Research. 3, 11, p. 803-809  Abstract
50.
p53: The ultimate tumor suppressor gene?
Oren M. (1992) FASEB Journal. 6, 13, p. 3169-3176  Abstract
49.
Oren M. (1992) Cancer and Metastasis Reviews. 11, 2, p. 141-148  Abstract
48.
Yaacov B. & Oren M. (1992) EMBO Journal. 11, 6, p. 2115-2121  Abstract

1991

47.
EIZENBERG O. & Oren M. (1991) Biochimica et Biophysica Acta - Gene Structure and Expression. 1129, 1, p. 34-42  Abstract
46.
Frequent p53 mutations in chemically induced murine fibrosarcoma
Halevy O., RODEL J., Peled A. & Oren M. (1991) Oncogene. 6, 9, p. 1593-1600  Abstract
45.
Michael D., YEHIELY F., GOTTLIEB E. & Oren M. (1991) Journal of Virology. 65, 8, p. 4160-4168  Abstract
44.
Transfected mouse c-jun can inhibit transformation of primary rat embryo fibroblasts
GINSBERG D., HIRAI S., PINHASIKIMHI O., Yaniv M. & Oren M. (1991) Oncogene. 6, 4, p. 669-672  Abstract
43.
MICHALOVITZ D., Halevy O. & Oren M. (1991) Journal of Cellular Biochemistry. 45, 1, p. 22-29  Abstract
42.
Yonish-Rouach E., Resnftzky D., Lotem J., Sachs L., Kimchi A. & Oren M. (1991) Nature. 352, 6333, p. 345-347  Abstract
41.
Wild-type p53 can down-modulate the activity of various promoters
GINSBERG D., MECHTA F., Yaniv M. & Oren M. (1991) Proceedings of the National Academy of Sciences of the United States of America. 88, 22, p. 9979-9983  Abstract
40.
Ginsberg D., Michael D. & Oren M. (1991) Molecular and Cellular Biology. 11, 1, p. 582-585  Abstract

1990

39.
Protein-binding elements in the promoter region of the mouse p53 gene
GINSBERG D., Oren M., Yaniv M. & PIETTE J. (1990) Oncogene. 5, 9, p. 1285-1290  Abstract
38.
MICHALOVITZ D., Halevy O. & Oren M. (1990) Cell. 62, 4, p. 671-680  Abstract
37.
Eliyahu D., Michael D. Y., Eliyahu S., Pinchas-Kimhi O. & Oren M. (1990) Oncogenes in Cancer Diagnosis. Bartram CR., Munk K. & Schwab M.(eds.). p. 125-134  Abstract
36.
Halevy O., MICHALOVITZ D. & Oren M. (1990) Science. 250, 4977, p. 113-116  Abstract
35.
Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells
Reihsaus E., Kohler M., Kraiss S., Oren M. & Montenarh M. (1990) Oncogene. 5, 1, p. 137-145  Abstract

1989

34.
Eliyahu D., MICHALOVITZ D., ELIYAHU S., PINHASIKIMHI O. & Oren M. (1989) Proceedings of the National Academy of Sciences of the United States of America. 86, 22, p. 8763-8767  Abstract
32.
Michalovitz D., Amsterdam A. & Oren M. (1989) Current Topics in Microbiology and Immunology. 144, p. 63-75  Abstract

1988

31.
METH-A FIBRO-SARCOMA CELLS EXPRESS 2 TRANSFORMING MUTANT P53 SPECIES
Eliyahu D., Goldfinger N., PINHASIKIMHI O., SHAULSKY G., SKURNIK Y., ARAI N., Rotter V. & Oren M. (1988) Oncogene. 3, 3, p. 313-321  Abstract
30.
Finlay C. A., Hinds P. W., Tan T. H., Eliyahu D., Oren M. & Levine A. J. (1988) Molecular and Cellular Biology. 8, 2, p. 531-539  Abstract
29.
Complex Formation Between the p53 Cellular Tumor Antigen and Nuclear Heat Shock Proteins
Michalovitz (Michael) D., Pinhasi-Kimchi O., Eliyahu D., Ben-Ze'ev A. & Oren M. (1988) Cellular and Molecular Biology of Tumors and Potential Application. Liss A. R., Minna J. & Kuehl WM.(eds.). Vol. 56. p. 247-259 (trueUCLA Symposia on Molecular & Cellular Biology).  Abstract
28.
Kraiss S., Quaiser A., Oren M. & Montenarh M. (1988) Journal of Virology. 62, 12, p. 4737-4744  Abstract
27.
Amsterdam A., Zauberman A., Meir G., PINHASIKIMHI O., SUH B. & Oren M. (1988) Proceedings of the National Academy of Sciences of the United States of America. 85, 20, p. 7582-7586  Abstract

1987

26.
Michalovitz D., Fischer-Fantuzzi L., Vesco C., Pipas J. M. & Oren M. (1987) Journal of Virology. 61, 8, p. 2648-2654  Abstract
25.
Inhibition of cell growth mediated by plasmids encoding p53 anti-sense
SHOHAT O., Greenberg M., REISMAN D., Oren M. & Rotter V. (1987) Oncogene. 1, 3, p. 277-283  Abstract

1986

24.
Michalovitz D., Eliyahu D. & Oren M. (1986) Molecular and Cellular Biology. 6, 10, p. 3531-3536  Abstract
23.
MOAV B., HOROWITZ M., COHEN J., RECHAVI G., Eliyahu E., Oren M. & Givol D. (1986) Gene. 48, 3-Feb, p. 297-300  Abstract
22.
PINHASIKIMHI O., MICHALOVITZ D., Ben-Ze'ev A. & Oren M. (1986) Nature. 320, 6058, p. 182-185  Abstract
21.
KACZMAREK L., Oren M. & BASERGA R. (1986) Experimental Cell Research. 162, 1, p. 268-272  Abstract

1985

20.
BIENZ-TADMOR B., ZAKUT-HOURI R., LIBRESCO S., Givol D. & Oren M. (1985) The EMBO Journal. 4, 12, p. 3209-3213  Abstract
19.
Oren M. (1985) Biochimica et Biophysica Acta - Reviews on Cancer. 823, 1, p. 67-78  Abstract
18.
Eliyahu D., Michalovitz D. & Oren M. (1985) Nature. 316, 6024, p. 158-160  Abstract
17.
ZAKUT-HOURI R., BIENZ-TADMOR B., Givol D. & Oren M. (1985) The EMBO Journal. 4, 5, p. 1251-1255  Abstract
16.
ROGEL A., Popliker M., WEBB C. & Oren M. (1985) Molecular and Cellular Biology. 5, 10, p. 2851-2855  Abstract
15.
Le Beau M. M., Westbrook C. A., Diaz M. O., Rowley J. D. & Oren M. (1985) Nature. 316, 6031, p. 826-828  Abstract

1984

14.
Wolf D., Admon S., Oren M. & Rotter V. (1984) Molecular and Cellular Biology. 4, 3, p. 552-558  Abstract
13.
Analysis of the gene coding for the murine cellular tumour antigen p53.
Bienz B., Zakut-Houri R., Givol D. & Oren M. (1984) The EMBO Journal. 3, 9, p. 2179-2183  Abstract
12.
Pinhasi O. & Oren M. (1984) Molecular and Cellular Biology. 4, 10, p. 2180-2186  Abstract
11.
Eliyahu D., Raz A., GRUSS P., Givol D. & Oren M. (1984) Nature. 312, 5995, p. 646-649  Abstract
10.
CZOSNEK H., BIENZ B., Givol D., ZAKUTHOURI R., PRAVTCHEVA D., RUDDLE F. & Oren M. (1984) Molecular and Cellular Biology. 4, 8, p. 1638-1640  Abstract

1983

9.
Oren M., BIENZ B., Givol D., RECHAVI G. & ZAKUT R. (1983) The EMBO Journal. 2, 10, p. 1633-1639  Abstract
8.
Oren M. & Levine A. J. (1983) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 80, 1 I, p. 56-59  Abstract
7.
Zakut-Houri R., Oren M., Bienz B., Lavie V., Hazum S. & Givol D. (1983) Nature. 306, 5943, p. 594-597  Abstract

1982

6.
GIDONI D., SCHELLER A., BARNET B., HANTZOPOULOS P., Oren M. & PRIVES C. (1982) Unknown Journal. 42, 2, p. 456-466  Abstract

1980

5.
Oren M., Winocour E. & PRIVES C. (1980) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 77, 1, p. 220-224  Abstract

1979

4.
DNA-BINDING AND SEDIMENTATION PROPERTIES OF SV40 T-ANTIGENS SYNTHESIZED INVIVO AND INVITRO
PRIVES C., BECK Y., GIDONI D., Oren M. & SHURE H. (1979) Cold Spring Harbor Symposia on Quantitative Biology. 44, p. 123-130  Abstract

1978

3.
Oren M., Lavi S. & Winocour E. (1978) Virology. 85, 2, p. 404-421  Abstract

1977

2.
Gluzman Y., Davison J., Oren M. & Winocour E. (1977) Journal of Virology. 22, 2, p. 256-266  Abstract

1976

1.
Oren M., Kuff E. L. & Winocour E. (1976) Virology. 73, 2, p. 419-430  Abstract